Dexmedetomidine (sublingual)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dexmedetomidine (sublingual), covering 2026-04-14 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Sublingual Dexmedetomidine for Treating Opioid Withdrawal [Phase 1, Phase 2]